Our industry-leading research and development team includes more than 45+ PhD scientists pioneering effective, research-backed probiotic, prebiotic and enzyme solutions.
You can see our commitment to science and research reflected in 7 state-of-the-art R&D centers; in vivo, in vitro and case studies; and published clinical trials.
Research on our probiotics and enzymes has been published in reputed peer-reviewed scientific journals.
Three published studies in 2021 alone found ImmunoSEB™, a systemic enzyme complex, and ProbioSEB CSC3™, a spore-forming, shelf-stable probiotic blend, showed promising results in participants with the virus and post-viral fatigue.
The NIH has even included ImmunoSEB™ and ProbioSEB CSC3™ in a COVID-19 dietary supplement fact sheet for health professionals.